Incidence of Invasive Fungal Infection during Primary Antifungal Prophylaxis in Acute Myeloid Leukaemia Patients at MDAnderson Cancer Center, 2009 – 2011

Ref ID: 17791

Author:

Marisa Z. R. Gomes, M.D., M.Sc., Ph.D.1,2, Russell E. Lewis, Pharm.D., F.C.C.P., B.C.P.S.1,
Paula Molinari C. M. Farias, M.D.1, Cai Wu1, Dimitrios P. Kontoyiannis, M.D., Sc.D., F.A.C.P., F.I.D.S.A.1

Author address:

1The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
2Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil;
mrgomes@mdanderson.org; marisargomes@ioc.fiocruz.br

Full conference title:

22nd European Congress of Clinical Microbiology and Infectious Diseases

Abstract:

Primary antifungal prophylaxis (PAP) with azoles and echinocandins has been commonly used in patients with acute myeloid leukaemia (AML) during chemotherapy and periods of immunosupression. However, the incidence densities of invasive fungal infections (IFIs) during primary prophylaxis are not well described. The purpose was to investigate the incidence of IFIs in patients with AML at M.D. Anderson Cancer Center.

Abstract Number: P870

Conference Poster: y

Conference Year: 2012

Link to conference website: NULL

New link: NULL

Conference abstracts, posters & presentations

Showing 10 posts of 17325 posts found.

  • Title

    Author

    Year

    Number

    Poster